FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1960438265> ?p ?o ?g. }

• W1960438265 endingPage "822" @default.
• W1960438265 startingPage "813" @default.
• W1960438265 abstract "Study Objective To estimate the impact of adherence to and persistence with atypical antipsychotics on health care costs and risk of hospitalization by controlling potential sources of endogeneity. Design Retrospective cohort study using medical and pharmacy claims data. Data Source Humana health care insurance database. Patients A total of 32,374 patients with a diagnosis of schizophrenia or bipolar disorder and who had a prescription for noninjectable atypical antipsychotics (aripiprazole, asenapine, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, or ziprasidone), after a washout period of at least 180 days during which there was no use of any atypical antipsychotics, between January 2007 and June 2013. Measurements and Main Results The effects of adherence (proportion of days covered by all atypical antipsychotic prescription fills) to and persistence (time from initiation to discontinuation of therapy) with atypical antipsychotics on outcomes (all‐cause total health care costs, medication costs, medical services costs, and inpatient admissions) were examined. To exclude potential bias due to mutual causality between drug use patterns and health care utilization, the effects of adherence and persistence measured in the first year on outcomes measured in the second year were investigated. Instrumental variable regressions using reimbursement rate and mail order as instrumental variables were conducted to correct potential endogeneity due to omitted variable bias. Being adherent decreased total costs by $19,497 (p<0.05), increased medication costs by $8194 (p<0.001), decreased medical services costs by $27,664 (p<0.001), and reduced hospitalization risk by 27% (p<0.001). Being persistent decreased individual total costs by $23,927 (p<0.05), increased medication costs by $10,278 (p<0.001), and decreased medical services costs by $34,178 (p<0.001). We could not identify a significant association between persistence and the risk of hospitalization. Conclusion Good adherence to and persistence with atypical antipsychotics led to lower total costs than poor adherence and persistence. Thus efforts should be made to improve adherence and persistence in patients taking atypical antipsychotics." @default.
• W1960438265 created "2016-06-24" @default.
• W1960438265 creator A5036774952 @default.
• W1960438265 creator A5047400146 @default.
• W1960438265 date "2015-09-01" @default.
• W1960438265 modified "2023-10-16" @default.
• W1960438265 title "Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization" @default.
• W1960438265 cites W133857840 @default.
• W1960438265 cites W1496843021 @default.
• W1960438265 cites W1527087929 @default.
• W1960438265 cites W1968443086 @default.
• W1960438265 cites W1978480999 @default.
• W1960438265 cites W1984524168 @default.
• W1960438265 cites W1984570625 @default.
• W1960438265 cites W1985652007 @default.
• W1960438265 cites W1999766447 @default.
• W1960438265 cites W2003245298 @default.
• W1960438265 cites W2016363498 @default.
• W1960438265 cites W2018426132 @default.
• W1960438265 cites W2019651647 @default.
• W1960438265 cites W2028613509 @default.
• W1960438265 cites W2034189785 @default.
• W1960438265 cites W2039436613 @default.
• W1960438265 cites W2045227722 @default.
• W1960438265 cites W2057249463 @default.
• W1960438265 cites W2061326496 @default.
• W1960438265 cites W2068802033 @default.
• W1960438265 cites W2069024810 @default.
• W1960438265 cites W2077867097 @default.
• W1960438265 cites W2079578270 @default.
• W1960438265 cites W2084741079 @default.
• W1960438265 cites W2087684793 @default.
• W1960438265 cites W2088863821 @default.
• W1960438265 cites W2093806805 @default.
• W1960438265 cites W2095976945 @default.
• W1960438265 cites W2101031176 @default.
• W1960438265 cites W2111828299 @default.
• W1960438265 cites W2123653560 @default.
• W1960438265 cites W2130349970 @default.
• W1960438265 cites W2138418531 @default.
• W1960438265 cites W2139062201 @default.
• W1960438265 cites W2142137592 @default.
• W1960438265 cites W2143913225 @default.
• W1960438265 cites W2146050874 @default.
• W1960438265 cites W2156108549 @default.
• W1960438265 cites W2157029647 @default.
• W1960438265 cites W2167542732 @default.
• W1960438265 cites W2916950229 @default.
• W1960438265 cites W3124836821 @default.
• W1960438265 doi "https://doi.org/10.1002/phar.1634" @default.
• W1960438265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26406773" @default.
• W1960438265 hasPublicationYear "2015" @default.
• W1960438265 type Work @default.
• W1960438265 sameAs 1960438265 @default.
• W1960438265 citedByCount "41" @default.
• W1960438265 countsByYear W19604382652016 @default.
• W1960438265 countsByYear W19604382652017 @default.
• W1960438265 countsByYear W19604382652018 @default.
• W1960438265 countsByYear W19604382652019 @default.
• W1960438265 countsByYear W19604382652020 @default.
• W1960438265 countsByYear W19604382652021 @default.
• W1960438265 countsByYear W19604382652023 @default.
• W1960438265 crossrefType "journal-article" @default.
• W1960438265 hasAuthorship W1960438265A5036774952 @default.
• W1960438265 hasAuthorship W1960438265A5047400146 @default.
• W1960438265 hasBestOaLocation W19604382651 @default.
• W1960438265 hasConcept C118552586 @default.
• W1960438265 hasConcept C177713679 @default.
• W1960438265 hasConcept C194828623 @default.
• W1960438265 hasConcept C2426938 @default.
• W1960438265 hasConcept C2776412080 @default.
• W1960438265 hasConcept C2776619155 @default.
• W1960438265 hasConcept C2779626651 @default.
• W1960438265 hasConcept C2780057945 @default.
• W1960438265 hasConcept C2780211496 @default.
• W1960438265 hasConcept C2780494398 @default.
• W1960438265 hasConcept C2780634440 @default.
• W1960438265 hasConcept C2780864610 @default.
• W1960438265 hasConcept C36434225 @default.
• W1960438265 hasConcept C71924100 @default.
• W1960438265 hasConcept C98274493 @default.
• W1960438265 hasConceptScore W1960438265C118552586 @default.
• W1960438265 hasConceptScore W1960438265C177713679 @default.
• W1960438265 hasConceptScore W1960438265C194828623 @default.
• W1960438265 hasConceptScore W1960438265C2426938 @default.
• W1960438265 hasConceptScore W1960438265C2776412080 @default.
• W1960438265 hasConceptScore W1960438265C2776619155 @default.
• W1960438265 hasConceptScore W1960438265C2779626651 @default.
• W1960438265 hasConceptScore W1960438265C2780057945 @default.
• W1960438265 hasConceptScore W1960438265C2780211496 @default.
• W1960438265 hasConceptScore W1960438265C2780494398 @default.
• W1960438265 hasConceptScore W1960438265C2780634440 @default.
• W1960438265 hasConceptScore W1960438265C2780864610 @default.
• W1960438265 hasConceptScore W1960438265C36434225 @default.
• W1960438265 hasConceptScore W1960438265C71924100 @default.
• W1960438265 hasConceptScore W1960438265C98274493 @default.
• W1960438265 hasIssue "9" @default.
• W1960438265 hasLocation W19604382651 @default.

• next